Our Science
Rytvela is a first in-class IL-1 receptor peptide antagonist
OIL-1 receptor antagonist rytvela
Unmet needs | Rytvela | IL-1 natural antagonist* | PGF2a receptor inhibitors |
Hydroxy- progesterone caproate** |
Oxytocin receptor inhibitor** |
Addresses inflammation | ✓ | ✕ | ✕ | ✕ | ✕ |
Reduces PTB | ✓ | ✓ | ✓ | ✕ | ✓ |
Maintains innate immunity | ✓ | ✓ | ✓ | ✓ | ✓ |
Improves neonate outcomes | ✓ | ? | ? | ✕ | ✕ |
Why Rytvela is so efficient and promising to prevent preterm birth
